Full View

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, X Cen, B Shan, Q Zhao, T Xie… - Protein & …, 2021 - academic.oup.com
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …
被引用次数：82 相关文章

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X XU, Y SUN, X CEN, B SHAN, Q ZHAO, T XIE… - Protein & …, 2021 - pesquisa.bvsalud.org
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, X Cen, B Shan, Q Zhao, T Xie, Z Wang… - Protein&Cell, 2021 - protein-cell.net
Chaperone-mediated autophagy (CMA) is a lysosomedependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, X Cen, B Shan, Q Zhao… - Protein …, 2021 - utsouthwestern.elsevierpure.com
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model.

X Xu, Y Sun, X Cen, B Shan, Q Zhao, T Xie, Z Wang… - Protein & Cell, 2021 - europepmc.org
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …
[HTML] nih.gov

[HTML][HTML] Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, X Cen, B Shan, Q Zhao, T Xie, Z Wang… - Protein & Cell, 2021 - ncbi.nlm.nih.gov
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, X Cen, B Shan, Q Zhao, T Xie… - Protein & …, 2021 - pubmed.ncbi.nlm.nih.gov
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …
[HTML] springer.com

[HTML][HTML] Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, X Cen, B Shan, Q Zhao, T Xie, Z Wang… - Protein & Cell, 2021 - Springer
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, C Xufeng, S Bing, Z Qingwei… - Protein & …, 2021 - search.proquest.com
Chaperone-mediated autophagy (CMA) is a lysosome-dependent selective degradation
pathway implicated in the pathogenesis of cancer and neurodegenerative diseases …

Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model

X Xu, Y Sun, X Cen, B Shan, Q Zhao, T Xie, Z Wang… - Protein & Cell, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Chaperone-mediated autophagy (CMA) is a
lysosome-dependent selective degradation pathway implicated in the pathogenesis of …